High impact
Magnesium Sulfate Injections and Terbutaline Pump for Preterm Labor (CPB 0468, reviewed 2026-07-17)
Aetna·Effective Jul 17, 2026
HCPCS S9349 is officially defined as "Home infusion therapy, tocolytic infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem." HCPCS S9349 is referenced in 1 tracked payer policy change from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS S9349 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.